NCT00275548 arm group fc14521c6aafd41a49ffd4a7e768fc13 [clinicaltrials_resource:NCT00275548/arm-group/fc14521c6aafd41a49ffd4a7e768fc13]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00275548 arm group fc14521c6aafd41a49ffd4a7e768fc13 [clinicaltrials_resource:NCT00275548/arm-group/fc14521c6aafd41a49ffd4a7e768fc13]
Bio2RDF identifier
NCT00275548/arm-group/fc14521c6aafd41a49ffd4a7e768fc13
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 14521c6aafd41a49ffd4a7e768fc13
description [clinicaltrials_vocabulary:description]
This group of patients will re ...... nical symptoms of hepatitis C.
identifier
clinicaltrials_resource:NCT00275548/arm-group/fc14521c6aafd41a49ffd4a7e768fc13
title
NCT00275548 arm group fc14521c6aafd41a49ffd4a7e768fc13
@en
type
label
NCT00275548 arm group fc14521c ...... 4521c6aafd41a49ffd4a7e768fc13]
@en